SGS acquires CRO in the US

Published: 13-Jan-2020
Finance Analysis

Texas-based Thomas J. Stephens & Associates specialises in the cosmetic and personal care industry

SGS has acquired Thomas J. Stephens & Associates, Inc. (Stephens). Headquartered in Richardson, Texas (US) and with a facility in Phoenix, Arizona, Stephens is a nationally recognised clinical research organisation (CRO) serving the cosmetic and personal care industry. The company provides safety and efficacy testing and contract research services.

Founded in 1989, Stephens is a privately owned company and employs nearly 100 staff. The CRO generated approximately US$15 million in revenue in 2019.

“This acquisition expands SGS’s Consumer & Retail service portfolio in the clinical testing sector for cosmetic and personal care products in the US,” said Frankie Ng, CEO of SGS.

“The combination of Stephens and SGS Harrison Research Laboratories in New Jersey gives SGS a leading position in this field in the US,” he concluded.

See more

You may also like

Analysis

SGS expands testing capabilities at Glasgow facility

Read more
The new laboratory has added an additional 1,200 sq m to the existing facility and will be adjacent to SGS's existing global center of excellence for cell banks and viral vaccine biosafety

Trending Articles

  1. US$640m PPE deal: Ansell snaps up Kimberly-Clark’s Personal Protective Equipment business After years of assessment, Ansell has acquired Kimberly-Clark's PPE business, which includes the brands Kimtech and KleenGuard
  2. Integrity testing of HEPA filters: A practical approach Filtering the air in aseptic process areas is critical to maintaining the cleanliness of the production environment. Jesus Casas provides tips to ensure HEPA filters are fit for purpose once installed in your facility
  3. A guide to choosing the best particle sample point location Particle counting in pharmaceutical applications can be clearly segregated into one of three categories: certification, qualification and monitoring. Each category requires a different approach as explained by PMS' Mark Hallworth
  4. Endotoxin control in depyrogenation tunnels Understanding the way glassware is depyrogenated and how high concentrations of endotoxin can be used to assess how well depyrogenation tunnels are functioning is key to quality control. Tim Sandle explains
  5. Global industrial group Purever Industries acquires Ardmac Global industrial group, Purever Industries, has acquired the Irish headquartered international specialist contracting firm, Ardmac, for an undisclosed sum

Upcoming event

Pharmig Annual Pharmaceutical Microbiology Conference

20–21 November 2024 | Conference | Nottingham, UK See all

You may also like

Analysis

SGS expands testing capabilities at Glasgow facility

The new laboratory has added an additional 1,200 sq m to the existing facility and will be adjacent to SGS's existing global center of excellence for cell banks and viral vaccine biosafety
Regulatory

SGS establishes South Asia Centre of Excellence for elemental analysis

Laboratory in Chennai now operates three ICP-MS systems for compliance with updated ICH Q3D regulatory guidelines on elemental impurities
Analysis

SGS introduces in vitro toxicology testing at its Canadian lab

The investment includes an expansion of existing cell/tissue culture capabilities, flow cytometry and mass spectrometry facilities
Analysis

SGS to expand its facilities in Chicago, US

The biopharmaceutical analytical and bioanalytical contract solutions provider will invest more than US$1.7m to expand its testing capabilities
Manufacturing

SGS introduces GMP DNA sequencing service in Glasgow lab

SGS, a specialist bio/pharmaceutical, analytical and bioanalytical contract solutions provider, announced it has introduced a Sanger sequencing service at its Glasgow, UK, laboratory, to support genetic stability testing and perform identity testing on cell banks, plasmids and viral seeds/vectors
You need to be a subscriber to read this article.
Click here to find out more.
Manufacturing

Extractables and leachables testing in single use equipment

Andreas Nixdorf, Team Manager, SGS, looks at the complexities of appropriate testing to evaluate the potential of single use equipment to emit extractables and leachables into pharmaceutical products
Analysis

SGS opens dedicated facility for extractables and leachables testing

The lab in Wiesbaden, Germany, will help the pharmaceutical and biopharmaceutical sectors meet regulatory requirements
Subscribe now